Drug class
Nitrofuran antiprotozoal agent; trypanocidal drug
Mechanism of action
Undergoes nitroreductase-mediated reduction in Trypanosoma cruzi, generating reactive intermediates and oxidative stress that damage parasite DNA, proteins and other cellular components.
General use cases
- Treatment of Chagas disease (American trypanosomiasis) caused by Trypanosoma cruzi in paediatric and eligible adult patients; the specific product label determines age, weight and combination requirements
For general informational purposes only. Do not rely on, cross-reference, cite or use this information as evidence or support for legal, regulatory, commercial or other claims.
